Enhanced anti-tumor immunity ex vivo induced by GM-CSF gene transducted dendritic cell vaccine

By He Songbing   Wang Liang   Sun Kang   Zhang Yanyun   Li Dechun  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 178-182

Springer Publishing Company

Access to resources Recommend Favorite

GM-CSF at Relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy

By Fernberg J.-O.   Brosjö O.   Friesland S.   Masucci G.  

Medical Oncology, Vol. 18, Iss. 3, 2001-09 ,pp. : 231-235

Humana Press, Inc

Access to resources Recommend Favorite

In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1

By Gravekamp Claudia   Leal Belinda   Denny Ashley   Bahar Rumana   Lampkin Shellye   Castro Francisco   Kim Sun   Moore Dan   Reddick Robert  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 1067-1077

Springer Publishing Company

Access to resources Recommend Favorite

The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

By Cranmer Lee   Hersh Evan  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 613-631

Informa Healthcare

Access to resources Recommend Favorite

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF - results of a prospective randomised trial

By Hejna M.   Kostler W.J.   Raderer M.   Steger G.G.   Brodowicz T.   Scheithauer W.   Wiltschke C.   Zielinski C.C.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 1994-2002

Elsevier

Access to resources Recommend Favorite